Abstract:In this article, we develop nonparametric inference methods for comparing survival data across two samples, which are beneficial for clinical trials of novel cancer therapies where long-term survival is a critical outcome. These therapies, including immunotherapies or other advanced treatments, aim to establish durable effects. They often exhibit distinct survival patterns such as crossing or delayed separation and potentially leveling-off at the tails of survival curves, clearly violating the proportional hazards assumption and rendering the hazard ratio inappropriate for measuring treatment effects. The proposed methodology utilizes the mixture cure framework to separately analyze the cure rates of long-term survivors and the survival functions of susceptible individuals. We evaluate a nonparametric estimator for the susceptible survival function in the one-sample setting. Under sufficient follow-up, it is expressed as a location-scale-shift variant of the Kaplan-Meier (KM) estimator. It retains several desirable features of the KM estimator, including inverse-probability-censoring weighting, product-limit estimation, self-consistency, and nonparametric efficiency. In scenarios of insufficient follow-up, it can easily be adapted by incorporating a suitable cure rate estimator. In the two-sample setting, besides using the difference in cure rates to measure the long-term effect, we propose a graphical estimand to compare the relative treatment effects on susceptible subgroups. This process, inspired by Kendall's tau, compares the order of survival times among susceptible individuals. The proposed methods' large-sample properties are derived for further inference, and the finite-sample properties are examined through extensive simulation studies. The proposed methodology is applied to analyze the digitized data from the CheckMate 067 immunotherapy clinical trial.

Interval-specific censoring set adjusted Kaplan-Meier estimator

Restricted mean survival time for interval‐censored data

Estimation and Model Selection of Semiparametric Multivariate Survival Functions under General Censorship

Comparison of baseline covariate adjustment methods for restricted mean survival time

Copula-based Semiparametric Nonnormal Transformed Linear Model for Survival Data with Dependent Censoring

Adjusted restricted mean survival times in observational studies

Generalized Residual-Based Diagnostic Testing for Duration Models with Censoring

Cure-rate estimation under Case-1 interval censoring

Survival Estimation for Missing not at Random Censoring Indicators based on Copula Models

A conditional approach for regression analysis of case K interval-censored failure time data with informative censoring

Non-parametric cure rate estimation under insufficient follow-up using extremes

Estimand-based Inference in Presence of Long-Term Survivors

Left-censored recurrent event analysis in epidemiological studies: a proposal when the number of previous episodes is unknown

Improving estimation efficiency of case-cohort study with interval-censored failure time data

Nonparametric Confidence Intervals for the Ratio of Marginal Hazard Rates of Paired Survival Times

A discrete approximation method for modeling interval‐censored multistate data

Estimation and Confidence Bands of A Conditional Survival Function with Censoring Indicators Missing at Random

Semiparametric regression analysis of failure time data with dependent interval censoring

Analyzing Interval-Censored Recurrence Event Data with Adjusting Informative Observation Times by Propensity Scores

A Semiparametric Regression Method for Interval-Censored Data

Estimating the Survival Function Based on the Semi-Markov Model for Dependent Censoring.